[ENLARGE FLYER] Walk for Mesothelioma Sunday 7th May 2017 from 9:00—11:30am, registration from 8:00 am Majors Bay Reserve, Concord NSW 2138 The Walk for Mesothelioma acknowledges people living with mesothelioma and those who have experienced the consequences of this terrible disease. Please join us for our first Walk for Mesothelioma, the 4 km walk
Asbestos.com recently reported: Dr. Ken Takahashi joined the Asbestos Diseases Research Institute (ADRI) in Sydney, Australia, with some very lofty goals. The institute’s new director wants to make the world a safer place. “My goal is to help establish this institute as a global center of excellence for asbestos-related disease,” Takahashi told Asbestos.com. “The mandate here
In November 2016, World Monuments Fund organized a public event, the “Asbestos Building Materials Workshop,” in Yangon, Myanmar. The workshop—the first of its kind in Myanmar—related to WMF’s project at Judson First Baptist Church, as well as to the larger building inventory and general health issues in Myanmar; although thousands of buildings contain asbestos materials,
‘Get to kNOw Asbestos this November’ The Asbestos Awareness Campaign aims to educate Australian about the dangers of asbestos in and around homes because Australia has one of the highest rates of asbestos-related diseases in the world. With asbestos-related diseases continuing to increase among Australians as a direct result of exposure to asbestos fires during
Professor Nico van Zandwijk was invited by the Asbestos Disease Support Society (adss) to present at the 2016 Symposium on Asbestos related diseases Here and Now in Brisbane on the 19th October 2016. Professor van Zandwijk spoke about the latest developments in mesothelioma treatment and research to audience of 200. Professor van Zandwijk was presented
ADRI scientists and collaborators have published a special report on the clinical development of their microRNA-based treatment for mesothelioma. This report describes microRNA replacement therapy for cancer and the concept behind TargomiRs in the MesomiR-1 trial. It appears in the journal Epigenomics and can be found here
ADRI scientists have recently published an article in the British Journal of Cancer describing work on a blood biomarker for malignant pleural mesothelioma. It focuses on fibulin-3, a protein secreted by mesothelioma cells into the blood of patients. See here for a link to the paper.
Marissa Williams, a Research Assistant at ADRI, was recently awarded a full PhD scholarship from Sydney Catalyst to support her PhD studies at The University of Sydney. This highly competitive and sought after award will allow Marissa to embark on PhD studies, putting to use the experience she has gained after 3 years at ADRI.
ADRI, together with its neighbour the ANZAC Research Institute, is actively seeking high calibre honours and PhD candidates who demonstrate initiative and innovative thought for Hounours and PhD projects focusing on cancer research. Why choose Cancer Research at Concord Clinical School? We host state of the art research facilities at the Asbestos Diseases
Jocelyn McLean joins the Asbestos Diseases Research Institute (ADRI), after many years of caring for patients having surgery for lung cancer, mesothelioma and benign conditions at Royal Prince Alfred Hospital. Utilising her knowledge and experience of patient and carer needs and drawing from current survivorship research and carer need research she provides sensitive telephone and
Dr Steven Kao is a medical oncologist at the Chris O’Brien Lifehouse, Camperdown. He completed his PhD at the ADRI and focused his research on predictive and prognostic factors in malignant mesothelioma. Steven has a wide clinical, translational and psycho-social research interest in thoracic cancers including malignant mesothelioma and asbestos-related lung cancers. He was awarded
Victoria Keena joined the ADRI in August 2008 as a Senior Consultant after many years as the General Manager of the Woolcock Institute of Medical Research. Victoria assisted with fitout and development of the ADRI since it opened in January 2009. She has had extensive hands-on experience in the administration of a medical research institute.
Ross Flemons joined the ADRI in December 2009 as part time Accountant. His previous position was as Finance Manager at the Woolcock Institute of Medical Research where he worked for 14 years. Ross is CPA qualified and has vast experience with all financial matters relating to independent medical research organisations, including reporting, budgeting, payroll, compliance
Marissa Williams commenced work at ADRI in February 2012 as a research assistant, and began her PhD studies in 2015. She completed her undergraduate degree of Forensic Biology in Biomedical Science at the University of Technology Sydney and went on to undertake an honours project in paediatric oncology at the Tumour bank, Westmead Children’s Hospital.
Kim Mattock joined the ADRI in April 2010 as the Receptionist/Administrative Assistant of the Asbestos Diseases Research Institute. Kim previously worked in varied administration roles and fields, both corporate and government. Joining ADRI is a return to the Concord Hospital campus for Kim; in a ‘previous life’ she worked for various specialists throughout the Hospital.
Professor Ken Takahashi is the Director of the Asbestos Diseases Research Institute (ADRI), University of Sydney. After graduating from the School of Medicine, Keio University (Japan) and accomplishing clinical residency, he moved to the University of Occupational and Environmental Health, Japan. There he studied and worked for 31 years including 16 years as the Professor
Justin Crosbie joined ADRI in 2009 as the Information Systems Manager. He has completed a Science degree in Information Technology at the University of Technology, Sydney. Justin has previous experience working an information technology consultancy firms and also works for the ANZAC Research Institute on the Concord Campus.
Anne Warby joined the ADRI in 2013 as a research officer working with Dr Steven Kao. She is responsible for the coordination of two research studies, one investigating chemotherapy utilisation for patients with malignant mesothelioma, and the other a quality of life study in patients with malignant pleural mesothelioma. Anne has extensive experience in project
Kan joined ADRI as a Biobank Officer in 2013 on a part-time basis to assist with the management, maintenance and development of the tissue bank. He has completed his undergraduate degree of Medical Science at the University of Sydney and worked in a blood bank for a private company. Recently he has also completed a
Jenny Weismantel joined the ADRI in 2011 as a Volunteer through the Concord Hospital Volunteers. Jenny has a Bachelor of Business in accounting and has assisted the Administration Team in many tasks including the development of the grants calendar and cataloguing of samples from the Australian Mesothelioma Surveillance Program. Jenny has also participated in the
Dr Anthony Linton is a medical oncologist at Concord Repatriation General Hospital and the Northern Cancer Institute St Leonards, specialising primarily in thoracic malignancies including malignant pleural mesothelioma and lung cancer. Dr Linton undertakes rural outreach clinics at Dubbo Base Hospital and is a senior clinical lecturer at the University of Sydney. Anthony was the
Rebecca Hyland joined the ADRI in 2012 on a part-time basis to assist with the development of the Biobank database. Rebecca has a Masters of International Public Health and has experience in the management and maintenance of clinical databases. Rebecca previously had been the Clinical Database Coordinator of the Ovarian Cancer Study at the Garvan
Dr Ruby Lin joined the ADRI in May 2014 from the Ramaciotti Centre for Genomics. She completed PhD in 2003 and has been awarded >A$2.5m in competitive funding including as CI on 3 NHMRC project grants (most recently 2013-5, McMullen & Lin), ARC LIEF and a Cancer Institute Infrastructure Grant in 2005. She has 4
Associate Professor Glen Reid was appointed ADRI’s Senior Research Scientist in April 2009, and he established the Institute’s cell and molecular biology labs. He is also conjoint Associate Professor at The University of Sydney Medical School and Adjunct Professor at UTS. His research focuses on the identification of new markers and molecular targets for malignant
Sue joined ADRI in May, 2013 as a volunteer. Previously, Sue was an executive in primary schools and the Itinerant Vision Support service with the NSW Department of Education. She has a Bachelor of Educational Administration and graduate and post graduate studies in Hearing and Vision and Multicultural education. Sue has assisted the Administrative Team
Yuen Yee Cheng joined ADRI as a Research Fellow in March 2010. She completed her PhD at the Chinese University of Hong Kong where she starts her research in epigenetic alterations in gastric cancer. She then undertook two years of Postdoctoral training at the University of Hong Kong. Epigenetic gene regulation has been the major
Jason joined ADRI in February 2013, as a Research Fellow undertaking his PhD in the School of Psychology, University of Sydney. Jason completed his undergraduate and initial postgraduate education at the University of Tasmania from 1995 through to 2003. Since then he has been working as a Clinical Psychologist in Mental Health and has developed
Matthew Soeberg is a postdoctoral research fellow working on Part I of the ADRI’s Cancer Institute NSW Translational Program Grant. He is employed through University of Sydney’s Cancer Epidemiology and Services Research (CESR) group and is based at the Cancer Institute of New South Wales. He will help to develop epidemiological research projects using mesothelioma